+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Atrial Fibrillation Treatment Market Report by Disorder Type, Treatment Type, End-User, and Region 2024-2032

  • PDF Icon

    Report

  • 142 Pages
  • July 2024
  • Region: Global
  • IMARC Group
  • ID: 5647825
The global atrial fibrillation treatment market size reached US$ 7.8 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 19.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.7% during 2023-2032.

Atrial fibrillation (AFib) refers to a cardiac condition with irregular and rapid heart rate that increases the risks of stroke, heart failure and other heart-related complications. In this condition, the upper (atrial) chambers beat irregularly and out of coordination with the lower (ventricle) chambers of the heart, thereby causing heart palpitations, shortness of breath and fatigue. It can also lead to the development of blood clots that may disrupt the blood flow to other organs. The main types of AFib include paroxysmal, persistent, long-term persistent, and permanent AFib that can be treated with medications and other interventions to adjust the heart’s electrical impulses.

The rising prevalence of cardiovascular diseases (CVDs) is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs). This, along with the steadily increasing geriatric population across the globe, is providing a boost to the market growth. Furthermore, the increasing preference for minimally invasive (MI) surgical procedures is also creating a positive impact on the demand for miniaturized surgical devices, implant surgeries and remote nursing. Additionally, various technological advancements, such as the development of catheter ablation devices to remove damaged heart tissues and innovative mapping and recording systems, is acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further.

Key Market Segmentation:

The report provides an analysis of the key trends in each sub-segment of the global atrial fibrillation treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on disorder type, treatment type and end-user.

Breakup by Disorder Type:

Paroxysmal Atrial Fibrillation
Persistent Atrial Fibrillation
Permanent Atrial Fibrillation
Others

Breakup by Treatment Type:

Medical Procedures
Surgical Procedures
Maze Surgery
Catheter Ablation
Non-Surgical Procedures
Electric Cardioversion
Diagnostic Catheters
Mapping and Recording Systems
Cardiac Monitors
Access Devices
Left Atrial Appendage and Closure Devices
Intracardiac Echocardiography (ICE) Systems
Medication
Anticoagulants
Anti-Arrhythmics

Breakup by End-User:

Hospitals
Cardiac Labs
Ambulatory Surgical Centers
Others

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Atricure Inc., Biotronik, Boston Scientific Corporation, Cardiofocus Inc., Hansen Medical Inc. (Auris Health), Johnson & Johnson, Siemens Healthineers, Stereotaxis Inc., etc.

Key Questions Answered in This Report:

How has the global atrial fibrillation treatment market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global atrial fibrillation treatment market?
What are the key regional markets?
What is the breakup of the market based on the disorder type?
What is the breakup of the market based on the treatment type?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global atrial fibrillation treatment market and who are the key players?
What is the degree of competition in the industry?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Atrial Fibrillation Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Disorder Type
6.1 Paroxysmal Atrial Fibrillation
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Persistent Atrial Fibrillation
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Permanent Atrial Fibrillation
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Treatment Type
7.1 Medical Procedures
7.1.1 Market Trends
7.1.2 Surgical Procedures
7.1.2.1 Maze Surgery
7.1.2.2 Catheter Ablation
7.1.3 Non-Surgical Devices
7.1.3.1 Electric Cardioversion
7.1.3.2 Diagnostic Catheters
7.1.3.3 Mapping and Recording Systems
7.1.3.4 Cardiac Monitors
7.1.3.5 Access Devices
7.1.3.6 Left Atrial Appendage and Closure Devices
7.1.3.7 Intracardiac Echocardiography (ICE) Systems
7.1.4 Market Forecast
7.2 Medications
7.2.1 Market Trends
7.2.2 Drug Class
7.2.2.1 Anticoagulants
7.2.2.2 Anti-Arrhythmics
7.2.3 Market Forecast
8 Market Breakup by End-User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cardiac Labs
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Ambulatory Surgical Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Atricure Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Biotronik
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Boston Scientific Corporation
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 SWOT Analysis
13.3.5 Cardiofocus Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 Hansen Medical Inc. (Auris Health)
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 Johnson & Johnson
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Siemens Healthineers
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.9 Stereotaxis Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
List of Figures
Figure 1: Global: Atrial Fibrillation Treatment Market: Major Drivers and Challenges
Figure 2: Global: Atrial Fibrillation Treatment Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Atrial Fibrillation Treatment Market: Breakup by Disorder Type (in %), 2023
Figure 4: Global: Atrial Fibrillation Treatment Market: Breakup by Treatment Type (in %), 2023
Figure 5: Global: Atrial Fibrillation Treatment Market: Breakup by End-User (in %), 2023
Figure 6: Global: Atrial Fibrillation Treatment Market: Breakup by Region (in %), 2023
Figure 7: Global: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 8: Global: Atrial Fibrillation Treatment (Paroxysmal Atrial Fibrillation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Atrial Fibrillation Treatment (Paroxysmal Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Atrial Fibrillation Treatment (Persistent Atrial Fibrillation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Atrial Fibrillation Treatment (Persistent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Atrial Fibrillation Treatment (Permanent Atrial Fibrillation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Atrial Fibrillation Treatment (Permanent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Atrial Fibrillation Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Atrial Fibrillation Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Atrial Fibrillation Treatment (Medical Procedures) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Atrial Fibrillation Treatment Market (Medical Procedures): Breakup by Type (in %), 2023
Figure 18: Global: Atrial Fibrillation Treatment Market (Surgical Procedures): Breakup by Type (in %), 2023
Figure 19: Global: Atrial Fibrillation Treatment (Medical Procedures) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Atrial Fibrillation Treatment (Medication) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Atrial Fibrillation Treatment Market (Medication): Breakup by Drug Classes (in %), 2023
Figure 22: Global: Atrial Fibrillation Treatment (Medication) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Atrial Fibrillation Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Atrial Fibrillation Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Atrial Fibrillation Treatment (Cardiac Labs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Atrial Fibrillation Treatment (Cardiac Labs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Atrial Fibrillation Treatment (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Atrial Fibrillation Treatment (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Atrial Fibrillation Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Atrial Fibrillation Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: North America: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: North America: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: United States: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: United States: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Canada: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Canada: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Asia Pacific: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Asia Pacific: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: China: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: China: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Japan: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Japan: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: India: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: India: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: South Korea: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: South Korea: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Australia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Australia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Indonesia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Indonesia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Europe: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Europe: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Germany: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Germany: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: France: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: France: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: United Kingdom: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: United Kingdom: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Italy: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Italy: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Spain: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Spain: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Russia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Russia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Latin America: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Latin America: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Brazil: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Brazil: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Mexico: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Mexico: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Middle East and Africa: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Middle East and Africa: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Global: Atrial Fibrillation Treatment Industry: SWOT Analysis
Figure 80: Global: Atrial Fibrillation Treatment Industry: Value Chain Analysis
Figure 81: Global: Atrial Fibrillation Treatment Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Atrial Fibrillation Treatment Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Disorder Type (in Million US$), 2024-2032
Table 3: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
Table 4: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by End-User (in Million US$), 2024-2032
Table 5: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Atrial Fibrillation Treatment Market Structure
Table 7: Global: Atrial Fibrillation Treatment Market: Key Players

Companies Mentioned

  • Abbott Laboratories
  • Atricure Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Cardiofocus Inc.
  • Hansen Medical Inc. (Auris Health)
  • Johnson & Johnson
  • Siemens Healthineers
  • Stereotaxis Inc.

Methodology

Loading
LOADING...

Table Information